The effectiveness of decongestive treatments provided within 12 months of developing a swollen arm for women with breast cancer-related lymphedema: a systematic review protocol of quantitative evidence

Eunice Jeffs; Debra  Bick

doi:10.11124/jbisrir-2014-1886

The effectiveness of decongestive treatments provided within 12 months of developing a swollen arm for women with breast cancer-related lymphedema: a systematic review protocol of quantitative evidence

Eunice Jeffs, Debra Bick

Midwifery

Research output: Contribution to journal › Article › peer-review

Abstract

The objective of this review is to identify the effectiveness of decongestive lymphedema treatment to reduce excess limb volume or improve patient-centered outcomes for women presenting within 12 months of developing a swollen arm due to breast cancer-related lymphedema.

More specifically, the objectives are to identify:
1) The most effective combination of treatment elements
2) The optimal duration of treatment.

Original language	English
Pages (from-to)	105 - 116
Number of pages	12
Journal	JBI Database of Systematic Reviews and Implementation reports
Volume	12
Issue number	11
DOIs	https://doi.org/10.11124/jbisrir-2014-1886
Publication status	Published - 1 Dec 2014

Keywords

lymphoedema
Breast Cancer
decongestive lymphoedema treatment (DLT)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.11124/jbisrir-2014-1886

Cite this

@article{89064b32476440d1bb492fb8913c3824,

title = "The effectiveness of decongestive treatments provided within 12 months of developing a swollen arm for women with breast cancer-related lymphedema: a systematic review protocol of quantitative evidence",

abstract = " The objective of this review is to identify the effectiveness of decongestive lymphedema treatment to reduce excess limb volume or improve patient-centered outcomes for women presenting within 12 months of developing a swollen arm due to breast cancer-related lymphedema.More specifically, the objectives are to identify:1) The most effective combination of treatment elements2) The optimal duration of treatment. ",

keywords = "lymphoedema, Breast Cancer, decongestive lymphoedema treatment (DLT)",

author = "Eunice Jeffs and Debra Bick",

year = "2014",

month = dec,

day = "1",

doi = "10.11124/jbisrir-2014-1886",

language = "English",

volume = "12",

pages = "105 -- 116",

journal = "JBI Database of Systematic Reviews and Implementation reports",

issn = "1838-2142",

publisher = "Joanna Briggs Institute",

number = "11",

}

The effectiveness of decongestive treatments provided within 12 months of developing a swollen arm for women with breast cancer-related lymphedema: a systematic review protocol of quantitative evidence. / Jeffs, Eunice ; Bick, Debra .
In: JBI Database of Systematic Reviews and Implementation reports, Vol. 12, No. 11, 01.12.2014, p. 105 - 116.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - The effectiveness of decongestive treatments provided within 12 months of developing a swollen arm for women with breast cancer-related lymphedema: a systematic review protocol of quantitative evidence

AU - Jeffs, Eunice

AU - Bick, Debra

PY - 2014/12/1

Y1 - 2014/12/1

N2 - The objective of this review is to identify the effectiveness of decongestive lymphedema treatment to reduce excess limb volume or improve patient-centered outcomes for women presenting within 12 months of developing a swollen arm due to breast cancer-related lymphedema.More specifically, the objectives are to identify:1) The most effective combination of treatment elements2) The optimal duration of treatment.

AB - The objective of this review is to identify the effectiveness of decongestive lymphedema treatment to reduce excess limb volume or improve patient-centered outcomes for women presenting within 12 months of developing a swollen arm due to breast cancer-related lymphedema.More specifically, the objectives are to identify:1) The most effective combination of treatment elements2) The optimal duration of treatment.

KW - lymphoedema

KW - Breast Cancer

KW - decongestive lymphoedema treatment (DLT)

U2 - 10.11124/jbisrir-2014-1886

DO - 10.11124/jbisrir-2014-1886

M3 - Article

SN - 1838-2142

VL - 12

SP - 105

EP - 116

JO - JBI Database of Systematic Reviews and Implementation reports

JF - JBI Database of Systematic Reviews and Implementation reports

IS - 11

ER -

The effectiveness of decongestive treatments provided within 12 months of developing a swollen arm for women with breast cancer-related lymphedema: a systematic review protocol of quantitative evidence

Abstract

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this